Printer Friendly

Daxor Announces UMDNJ of Newark, NJ Acquires Blood Volume Analyzer BVA-100.

NEW YORK -- Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the University of Medicine and Dentistry of New Jersey (UMDNJ) of Newark, New Jersey.

As the core teaching facility of the UMDNJ-New Jersey Medical School, The University Hospital is the center of referral for many of the stateeIUs most advanced medical services and specialty care programs. UMDNJeIUs commitment to education, primary care and specialized referral services has produced the most extensive array of inpatient and outpatient services available in the state of New Jersey.

DaxoreIUs Blood Volume Analyzer BVA-100 will be located within the University HospitaleIUs Nuclear Medicine Department. The University Hospital offers a wide range of specialty services, including northern New JerseyeIUs only Level 1 Trauma Center (incorporating a trauma-intensive care unit and the NorthSTAR helicopter emergency and critical care transport system), the Acute Stroke Center, the New Jersey Cardiovascular Institute (NJCI), the neurosurgical intensive care unit and a special Brain Tumor Program, the Neurological Institute of New Jersey, The University Center for Bloodless Surgery and Medicine, and New JerseyeIUs first Liver Transplant Program.

The hospital is staffed by 300 full-time attending physicians who are also faculty members of the New Jersey Medical School. The University Hospital has more than 19,000 admissions, 2,700 births, and 215,000 outpatient visits annually.

A measured blood volume has been shown in recent published medical reports to be clinically superior in the diagnosis of a patienteIUs volume status than existing surrogate markers, lab test and physical assessments within medical conditions such as heart failure and critical care.

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. For more information regarding Daxor CorporationeIUs Blood Volume Analyzer BVA-100, visit DaxoreIUs website www.Daxor.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 27, 2006
Words:308
Previous Article:AOL Music and The Who Bring Fans Exclusive Live Performances.
Next Article:Pixelworks(R) Shareholders Approve Voluntary Stock Option Exchange Program for Employees.
Topics:


Related Articles
N.J. developer organizes MS benefit.
Italian-Americans honor Petillo.
Daxor Announces San Jacinto Methodist Hospital of Baytown, TX Acquires Blood Volume Analyzer BVA-100.
Daxor Announces Christiana Care Health System of Newark, DE Purchases Blood Volume Analyzer BVA-100.
Daxor Announces Significant Blood Volume Data Using the BVA-100 Reported at Heart Failure Society of America Annual Scientific Meeting.
Daxor Announces Geisinger Medical Center in Danville, PA Acquires BVA-100 Blood Volume Analyzer.
Daxor Announces Alfieri Cardiology of Newark, DE Acquires Blood Volume Analyzer BVA-100.
Daxor Announces Carolinas Medical Center of Charlotte, NC Purchases BVA-100 and Blood Volume Kit Usage Increases 40%.
Daxor Announces Sacred Heart Hospital in Allentown, PA Acquires Blood Volume Analyzer BVA-100.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters